Ask Our Expert: Insights into robust leachables strategies for biologic drugs
As biologic products become more complex, understanding the potential impact of leachables is increasingly important. Our Ask Our Expert article examines the scientific considerations for leachables assessment, analytical challenges associated with biologics, and strategies to support product development, regulatory submissions and lifecycle management.
Whether developing novel biologics, biosimilars or combination products, manufacturers face growing expectations to demonstrate a thorough understanding of potential leachables risks.
Complete the form now to access expert perspectives on emerging industry trends, risk-based decision making and practical considerations for developing robust leachables programmes that support both compliance and long-term product success.
Whether developing novel biologics, biosimilars or combination products, manufacturers face growing expectations to demonstrate a thorough understanding of potential leachables risks.
Complete the form now to access expert perspectives on emerging industry trends, risk-based decision making and practical considerations for developing robust leachables programmes that support both compliance and long-term product success.